Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS CIPLA DECIPHER LABS/
CIPLA
 
P/E (TTM) x -2.1 32.2 - View Chart
P/BV x 0.6 5.2 12.4% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 DECIPHER LABS   CIPLA
EQUITY SHARE DATA
    DECIPHER LABS
Mar-23
CIPLA
Mar-23
DECIPHER LABS/
CIPLA
5-Yr Chart
Click to enlarge
High Rs631,185 5.3%   
Low Rs14852 1.6%   
Sales per share (Unadj.) Rs45.1281.9 16.0%  
Earnings per share (Unadj.) Rs-2.735.1 -7.6%  
Cash flow per share (Unadj.) Rs-2.249.7 -4.5%  
Dividends per share (Unadj.) Rs08.50 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs23.0289.2 7.9%  
Shares outstanding (eoy) m10.10807.15 1.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.93.6 23.6%   
Avg P/E ratio x-14.529.0 -50.0%  
P/CF ratio (eoy) x-17.320.5 -84.1%  
Price / Book Value ratio x1.73.5 47.6%  
Dividend payout %024.2 -0.0%   
Avg Mkt Cap Rs m389822,164 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m41238,301 1.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m456227,531 0.2%  
Other income Rs m745,121 1.4%   
Total revenues Rs m529232,653 0.2%   
Gross profit Rs m-10648,079 -0.2%  
Depreciation Rs m411,721 0.0%   
Interest Rs m51,095 0.4%   
Profit before tax Rs m-4240,384 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1512,029 -0.1%   
Profit after tax Rs m-2728,355 -0.1%  
Gross profit margin %-23.321.1 -110.3%  
Effective tax rate %35.529.8 119.2%   
Net profit margin %-5.912.5 -47.2%  
BALANCE SHEET DATA
Current assets Rs m201168,051 0.1%   
Current liabilities Rs m5050,333 0.1%   
Net working cap to sales %33.251.7 64.2%  
Current ratio x4.13.3 121.4%  
Inventory Days Days3073 41.1%  
Debtors Days Days7897 12,127.0%  
Net fixed assets Rs m71117,318 0.1%   
Share capital Rs m1011,614 6.3%   
"Free" reserves Rs m131231,845 0.1%   
Net worth Rs m232233,460 0.1%   
Long term debt Rs m00-   
Total assets Rs m272290,067 0.1%  
Interest coverage x-7.637.9 -20.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.70.8 213.9%   
Return on assets %-8.110.2 -79.8%  
Return on equity %-11.612.1 -95.2%  
Return on capital %-15.817.8 -89.2%  
Exports to sales %022.6 0.0%   
Imports to sales %08.9 0.0%   
Exports (fob) Rs mNA51,516 0.0%   
Imports (cif) Rs mNA20,202 0.0%   
Fx inflow Rs m064,282 0.0%   
Fx outflow Rs m020,202 0.0%   
Net fx Rs m044,080 0.0%   
CASH FLOW
From Operations Rs m-1632,377 -0.0%  
From Investments Rs m-43-23,885 0.2%  
From Financial Activity Rs m-22-9,583 0.2%  
Net Cashflow Rs m-80-968 8.3%  

Share Holding

Indian Promoters % 0.0 13.4 -  
Foreign collaborators % 16.4 20.0 82.0%  
Indian inst/Mut Fund % 0.0 50.0 -  
FIIs % 0.0 25.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 83.6 66.5 125.6%  
Shareholders   34,511 425,731 8.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on COMBAT DRUGS vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

COMBAT DRUGS vs Cipla Share Price Performance

Period COMBAT DRUGS Cipla S&P BSE HEALTHCARE
1-Day 0.68% 1.94% 1.18%
1-Month -17.62% 1.25% -0.75%
1-Year -1.07% 68.02% 61.82%
3-Year CAGR -24.12% 22.53% 18.16%
5-Year CAGR -10.83% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the COMBAT DRUGS share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of COMBAT DRUGS hold a 16.4% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of COMBAT DRUGS and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, COMBAT DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of COMBAT DRUGS, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.